IntegraGen SA stock analysis
IntegraGen SA ( ($FR:ALINT) ) just unveiled an update. IntegraGen reported estimated, unaudited first‑half 2026 revenue of €2.0 million, a 23% decline year‑on‑year, reflecting the impact of ongoing court‑supervised restructuring
An announcement from IntegraGen SA ( ($FR:ALINT) ) is now available. IntegraGen SA, a specialist in cancer genomics and rare genetic diseases, provides advanced DNA sequencing and genomic data interpretation
IntegraGen SA ( ($FR:ALINT) ) has shared an update. The Commercial Court of Évry has approved the full transfer of IntegraGen SA’s genomics and bioinformatics service business, including 16 employees,
IntegraGen S.A. provides advanced human genome analysis services to academic researchers and life science businesses across France. Their comprehensive genomic offerings include transcriptomics, epigenomics, DNA sequencing, next-generation sequencing (NGS) specifically for cancer research, and SNP genotyping. The company also delivers clinical research solutions, such as clinical-grade sequencing and pharmacogenomic studies, in addition to supporting fundamental human genetic investigations. For agricultural applications, IntegraGen offers agrigenomic services covering crop and livestock genotyping, as well as high-throughput sequencing for these domains. Their microbial genomics division conducts whole-genome microbial sequencing and transcriptomics. IntegraGen further develops a suite of sophisticated bioinformatics tools: MERCURY is an online platform for oncology, designed to transform raw high-throughput sequencing data into molecular reports for translational and clinical research. SIRIUS, a cloud-based software, empowers researchers to analyze whole genome, whole exome, and gene panel sequencing information. Galileo is another cloud application that enables dynamic exploration of RNA-Seq expression data. Finally, GeCo, their genomic consulting service, provides researchers access to expert biostatisticians and bioanalysts. Founded in 2000 and headquartered in Évry, France, IntegraGen S.A. is a subsidiary of OncoDNA SA.
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 3 | 12 |
| Technical Analysis | 3 | 3 | 4 |
| Moving Averages | 4 | 0 | 8 |
